Gain unprecedented kinetic insights into your CRISPR workflow with the CRISPR QC’s analytics platform
CRISPRQC INC. has raised $5.7M in total funding. The most recent round was Series A.
CRISPRQC INC. is headquartered in San Diego, CA.
Gain unprecedented kinetic insights into your CRISPR workflow with the CRISPR QC’s analytics platform
A failed CRISPR run leaves researchers with unanswered questions about gRNA design, RNP formation, DNA binding, and cleavage efficiency, often not discovered until after costly downstream assays.
CRISPR QC's CRISPR Analytics Platform gives real-time, quantitative kinetic measurements of RNP formation, DNA target binding, and cleavage activity to troubleshoot and optimize CRISPR workflows earlier.
It describes its assays as 'mechanism-aware,' surfacing functional behavior inside cells rather than black-box endpoints, and claims fewer blind optimization cycles and faster identification of failure modes.
Co-founded in 2021 by CEO Ross Bundy and Dr. Kiana Aran; the CRISPR analytics company raised a $10M Series A led by Xcellerant Ventures.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.